CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 65 enrolled
Drug / intervention
CochSyn devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07091071
NCT07091071N/ACompleted
CompareCT.gov

Evaluation of the CochSyn Device in Clinical Practice

University Ghent·interventional·Posted Jul 29, 2025·Updated Feb 10, 2026

In Brief

A clinical study evaluating CochSyn device for Hearing Loss, Sensorineural and 3 related conditions. Completed, enrolled 65 participants across 3 sites.

Detailed Summary

This study investigates a new type of auditory evoked brain potentials for the quantification and classification of peripheral hearing damage (The CochSyn Test). The study will investigate the characteristics of this new auditory evoked potential marker in a cohort of people with and without self-reported hearing difficulties and test a new type of hardware that was developed to conduct the test (the CochSyn Device) in clinical practice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural, Cochlear Hearing Loss, Cochlear Synaptopathy, DFNA9
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedJul 29, 2025
Enrollment StartOct 29, 2025
Primary CompletionJan 22, 2026
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11 months ago

Interventions

CochSyn devicedevice

The CochSyn device is intended for use in the evaluation of hearing-related disorders in adults using auditory evoked potentials. The CochSyn device records and analyses biopotential waveforms that can be used for hearing screening and diagnostic applications.